series-b
Stage
2007
Founded
2
Investors
About
Promimic’s state-of-the-art nanotechnology, HAnano Surface®, makes it possible to create a unique bioactive surface on any implant. HAnano Surface has demonstrated faster and stronger osseointegration in over 30 in vivo and in vitro studies, with over 150,000 clinical applications to date.
Explore Promimic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.